IN BRIEF: Induction Healthcare shares down as CEO Balmain steps down

Archived article

Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.

Induction Healthcare Group PLC - London-based digital health platform - Says Chief Executive Officer James Balmain is stepping down with immediate effect. Balmain will take on a new advisory role where he will directly ‘support the evolution and execution of group product strategy, together with national and regional sales’.

Says Non-Executive Chair Christopher Samler will assume the interim role of executive chair, providing day to day leadership of the business pending the recruitment of a new permanent CEO.

Balmain says: ‘I’m looking forward to spending much more of my time on product strategy and sales, whilst also supporting the business as it navigates an important transitional period.’

Current stock price: 20.40 pence, down 9.3%

12-month change: down 65%

By Xindi Wei, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.